Clinuvel Pharmaceuticals Limited (ASX:CUV)
Australia · Delayed Price · Currency is AUD 9.44
+0.07 (0.75%)
Aug 7, 2026, 4:10 PM AEST
Clinuvel Pharmaceuticals Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 36.14 | 28.02 | 35.2 | 31.89 | 121.51 | 82.69 |
Short-Term Investments | 196.86 | 196.09 | 148.67 | 124.92 | - | - |
Cash & Short-Term Investments | 233 | 224.11 | 183.87 | 156.81 | 121.51 | 82.69 |
Cash Growth | 3.97% | 21.88% | 17.25% | 29.05% | 46.94% | 23.89% |
Accounts Receivable | 16.58 | 24.17 | 25.01 | 20.64 | 15.9 | 15.81 |
Other Receivables | - | 3.3 | 1.23 | 1.57 | 0.3 | 0.28 |
Receivables | 16.58 | 27.46 | 26.24 | 22.21 | 16.2 | 16.09 |
Inventory | 8.41 | 8.82 | 10.63 | 9.52 | 1.83 | 3.19 |
Prepaid Expenses | - | - | - | - | 1.04 | 0.88 |
Other Current Assets | 3.38 | 2.58 | 1.33 | 1.07 | - | - |
Total Current Assets | 261.38 | 262.97 | 222.06 | 189.62 | 140.58 | 102.85 |
Property, Plant & Equipment | 6.48 | 7.13 | 7.72 | 2.85 | 2.7 | 2.6 |
Long-Term Investments | 0.22 | 0.21 | 0.13 | - | - | - |
Goodwill | - | - | - | - | 0.19 | 0.19 |
Other Intangible Assets | 0.19 | 0.19 | 0.19 | 0.19 | - | - |
Long-Term Deferred Tax Assets | 1.42 | 1.26 | 1.02 | 1.06 | 0.48 | 2.93 |
Total Assets | 269.7 | 271.75 | 231.12 | 193.71 | 143.95 | 108.57 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 10.68 | 2.55 | 2.35 | 2.79 | 0.26 | 4.66 |
Accrued Expenses | 2.51 | 2.29 | 1.88 | 1.45 | 2.86 | 3.7 |
Current Portion of Leases | 0.31 | 0.43 | 0.37 | 0.3 | 0.32 | 0.26 |
Current Income Taxes Payable | 4.36 | 14.55 | 15.85 | 16.09 | 7.28 | 0.1 |
Other Current Liabilities | - | 7.39 | 4.76 | 4.86 | 3.02 | - |
Total Current Liabilities | 17.85 | 27.21 | 25.21 | 25.49 | 13.73 | 8.71 |
Long-Term Leases | 0.02 | 0.1 | 0.51 | 0.7 | 0.94 | 1.05 |
Pension & Post-Retirement Benefits | - | 0.13 | 0.08 | 0.06 | 0.03 | 0.01 |
Long-Term Deferred Tax Liabilities | 2.62 | 3.42 | 2.23 | 2.76 | 3.62 | - |
Other Long-Term Liabilities | 0.19 | 0.09 | 0.08 | 0.07 | 0.07 | 0.06 |
Total Liabilities | 20.68 | 30.94 | 28.11 | 29.08 | 18.39 | 9.83 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 170.33 | 169.28 | 168.8 | 151.85 | 151.85 | 151.85 |
Retained Earnings | 71.57 | 63.63 | 29.96 | -9.77 | -38.4 | -58.13 |
Comprehensive Income & Other | 7.12 | 7.9 | 4.25 | 22.56 | 12.11 | 5.02 |
Total Common Equity | 249.02 | 240.81 | 203.01 | 164.63 | 125.56 | 98.74 |
Shareholders' Equity | 249.02 | 240.81 | 203.01 | 164.63 | 125.56 | 98.74 |
Total Liabilities & Equity | 269.7 | 271.75 | 231.12 | 193.71 | 143.95 | 108.57 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 0.32 | 0.53 | 0.88 | 1 | 1.26 | 1.3 |
Net Cash (Debt) | 232.68 | 223.58 | 182.99 | 155.81 | 120.25 | 81.39 |
Net Cash Growth | 4.07% | 22.18% | 17.44% | 29.57% | 47.75% | 24.39% |
Net Cash Per Share | 4.60 | 4.44 | 3.59 | 3.01 | 2.32 | 1.59 |
Filing Date Shares Outstanding | 50.16 | 50.12 | 50.08 | 49.41 | 49.41 | 49.41 |
Total Common Shares Outstanding | 50.16 | 50.12 | 50.08 | 49.41 | 49.41 | 49.41 |
Working Capital | 243.53 | 235.76 | 196.85 | 164.12 | 126.85 | 94.14 |
Book Value Per Share | 4.96 | 4.80 | 4.05 | 3.33 | 2.54 | 2.00 |
Tangible Book Value | 248.83 | 240.62 | 202.83 | 164.45 | 125.37 | 98.55 |
Tangible Book Value Per Share | 4.96 | 4.80 | 4.05 | 3.33 | 2.54 | 1.99 |
Land | - | 5.02 | 4.97 | - | - | - |
Machinery | - | 2.19 | 1.94 | 1.53 | 1.33 | 0.82 |
Leasehold Improvements | - | 1.99 | 1.99 | 1.89 | 1.25 | 1.25 |